# Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

> **NCT01106989** · PHASE2 · COMPLETED · sponsor: **ZARS Pharma Inc.** · enrollment: 20 (actual)

## Conditions studied

- Myofascial Pain Syndromes

## Interventions

- **DRUG:** Heated lidocaine/tetracaine patch

## Key facts

- **NCT ID:** NCT01106989
- **Lead sponsor:** ZARS Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106989, "Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01106989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*